Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yusuke Kurioka
Observed name:
Y. Kurioka
Institution:
Kochi Medical School Hospital
Observed institutions:
Japanese Red Cross Society, Japan,
Kochi Medical School Hospital,
Himeji Red Cross Hospital,
Kōchi University
OpenAlex ID:
A5087517300
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
2022
·
Tatsuki Ikoma
, Mototsugu Shimokawa
, et al.
·
Cancer Immunology Immunotherapy
·
24
FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
2020
·
Toshihiko Matsumoto
, Yusuke Kurioka
, et al.
·
Pancreas
·
18
Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
2022
·
Toshihiko Matsumoto
, Shogo Yamamura
, et al.
·
Journal of Clinical Medicine
·
14
PDF
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
2022
·
Akio Nakasya
, Yuya Hagiwara
, et al.
·
International Journal of Clinical Oncology
·
7
PDF
Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol
2023
·
Kayo Nakamura
, Etsuko Murakami
, et al.
·
Respiratory Medicine Case Reports
·
5
Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
2022
·
Yuya Hagiwara
, Akio Nakasya
, et al.
·
Journal of Gastrointestinal Oncology
·
5
PDF
Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy
2022
·
Tatsuki Ikoma
, Toshihiko Matsumoto
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing
2023
·
Tsutomu Namikawa
, Tomoki Tanaka
, et al.
·
Clinical Journal of Gastroenterology
·
4
Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
2022
·
Toshihiko Matsumoto
, Shogo Yamamura
, et al.
·
Clinical Medicine Insights Oncology
·
4
14-day versus 28-day trifluridine–tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
2026
·
Tomoki Sakakida
, Hiroya Taniguchi
, et al.
·
The Lancet
·
2
ASTRON (OGSG 2401): A multicenter prospective trial of ferric carboxymaltose without erythropoiesis-stimulating agents for iron deficiency anemia in patients with gastric/colorectal cancer receiving chemotherapy.
2026
·
Ryohei Kawabata
, Hiroki Yukami
, et al.
·
Journal of Clinical Oncology
103P Establishing a patient-derived tumour spheroid model using endoscopic biopsy specimens of gastrointestinal cancers
2024
·
H. Satake
, Y. Kurioka
, et al.
·
ESMO Open
Safety and efficacy of trifluridine/tipiracil in treatment of patients with advanced gastric cancer having ascites
2022
·
Toshihiko Matsumoto
, Shogo Yamamura
, et al.
·
Research Square
PDF
Safety and efficacy of trifluridine/tipiracil in treatment of patients with advanced gastric cancer having ascites
2022
·
Toshihiko Matsumoto
, Shogo Yamamura
, et al.
·
Research Square
Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.
2020
·
Toshihiko Matsumoto
, Ukyo Okazaki
, et al.
·
Journal of Clinical Oncology
FOLFIRINOX for advanced pancreatic cancer patients after nab-paclitaxel plus gemcitabine failure: retrospective analysis
2019
·
Toshihiko Matsumoto
, Shogo Kimura
, et al.
·
Annals of Oncology
PDF
Nivolumab for poor performance status patients : retrospective analysis
2019
·
Toshihiko Matsumoto
, Shogo Kimura
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
17
Citation count:
88
H-index:
5
I10-index:
3
Year
Topic
Type